Your browser doesn't support javascript.
loading
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.
Abubakar, Mustapha; Orr, Nick; Daley, Frances; Coulson, Penny; Ali, H Raza; Blows, Fiona; Benitez, Javier; Milne, Roger; Brenner, Herman; Stegmaier, Christa; Mannermaa, Arto; Chang-Claude, Jenny; Rudolph, Anja; Sinn, Peter; Couch, Fergus J; Devilee, Peter; Tollenaar, Rob A E M; Seynaeve, Caroline; Figueroa, Jonine; Sherman, Mark E; Lissowska, Jolanta; Hewitt, Stephen; Eccles, Diana; Hooning, Maartje J; Hollestelle, Antoinette; Martens, John W M; van Deurzen, Carolien H M; Bolla, Manjeet K; Wang, Qin; Jones, Michael; Schoemaker, Minouk; Wesseling, Jelle; van Leeuwen, Flora E; Van 't Veer, Laura; Easton, Douglas; Swerdlow, Anthony J; Dowsett, Mitch; Pharoah, Paul D; Schmidt, Marjanka K; Garcia-Closas, Montserrat.
Afiliación
  • Abubakar M; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK. Mustapha.Abubakar@icr.ac.uk.
  • Orr N; Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
  • Daley F; Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
  • Coulson P; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.
  • Ali HR; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Blows F; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Milne R; Centro de Investigacion en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
  • Brenner H; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
  • Stegmaier C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Australia.
  • Mannermaa A; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chang-Claude J; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Rudolph A; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sinn P; Saarland Cancer Registry, Saarland, Germany.
  • Couch FJ; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Devilee P; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Tollenaar RA; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Seynaeve C; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Figueroa J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sherman ME; Department of Pathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Lissowska J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Hewitt S; Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Eccles D; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Hollestelle A; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
  • Martens JW; Divisions of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • van Deurzen CH; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Bolla MK; Faculty of Medicine Academic Unit of Cancer Sciences, Southampton General Hospital, Southampton, UK.
  • Wang Q; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Jones M; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Schoemaker M; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Wesseling J; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Leeuwen FE; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Van 't Veer L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Easton D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.
  • Dowsett M; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.
  • Pharoah PD; Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Schmidt MK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Garcia-Closas M; Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Breast Cancer Res ; 18(1): 104, 2016 10 18.
Article en En | MEDLINE | ID: mdl-27756439
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Antígeno Ki-67 Tipo de estudio: Clinical_trials / Prognostic_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Antígeno Ki-67 Tipo de estudio: Clinical_trials / Prognostic_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido